Category Archives: IS NOVA CELLS RIGHT FOR YOU?

A list of conditions Nova Cells Institute has successfully treated

NOVA CELLS INSTITUTE NEWSCAST - August 8, 2015Learn more about each of the disorders below by either following the link, or emailing or placing a call. Nova Cells has successfully treated many other conditions so if you do not see your particular challenge here, just ask us about our experience with it!

ALS (Lou Gehrig’s disease) – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410

Autism – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410

Cancer Cancer (End-stage & advanced too): http://www.novacellsinstitute.com/cancer-stem-cell-therapy.html

Cardiovascular: https://ncimx.wordpress.com/category/reversing-blockage-in-blood-vessels/

Cerebral Palsyhttps://ncimx.wordpress.com/?s=Cerebral+Palsy

Chronic Fatigue Syndrome (CFS) – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410 

Dementia/Lewy Body Dementiahttps://ncimx.wordpress.com/?s=Dementia

Epilepsy/Other Seizure Disordershttps://ncimx.wordpress.com/?s=Seizure

Fibromyalgia – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410 

Fibrosis – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410 

Multiple sclerosishttps://ncimx.wordpress.com/?s=multiple+sclerosis

Parkinson’s Disease – See alzheimer’s-dementia

Spina Bifidahttps://ncimx.wordpress.com/?s=Spina+Bifida

Spinal Cord Injury/Paralysishttps://ncimx.wordpress.com/?s=spinal+cord+injury

Strokehttps://ncimx.wordpress.com/category/stroke/

Traumatic Brain Injury – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410 begin_of_the_skype_highlighting 

News9: News from Nova Cells Institute


NOVA CELLS INSTITUTE NEWSCAST - August 8, 2015

https://www.youtube.com/watch?v=GAS7IXWLe0s&list=PLySdDdYELg520yVeEwpu7BmwiZ1yu2QvO

Good news on #WorldLungCancerDay

LUNGS - FREE MS imageAugust 1 is #WorldLungCancerDay. This insidious form of cancer is one Nova Cells has had considerable success in treating. You can read more about the NCIM cancer program at http://www.novacellsinstitute.com/cancer-stem-cell-therapy.html

If you’d like specifics on advanced and end-stage cancer turnarounds* you should contact Grace Odgers, Ph.D. cand. using the information below:

OLYMPUS DIGITAL CAMERAWant to know more about NCIM and its pioneering immunologic treatment program for cancer? Call NCIM’s US information line at 1-562-916-3410 or email NCIM patient care facilitator/educator Grace Odgers, Ph.D. cand., by e-mail at gracepatients@gmail.com.

* Many, many cancer case histories have yet to be written up. Grace has specifics and will gladly share this with anyone who calls or emails her.

Wharton’s Jelly Stem Cells

NOVA CELLS INSTITUTE HARVESTS & MAKES CLINICAL USE OF STEM CELLS ISOLATED FROM (UMBILICAL CORD) stem cells from poweredtemplatesWHARTON’S JELLY. BELOW ARE LINKS  TO A SAMPLING OF PAPERS PUBLISHED ON WJ STEM CELLS: 

Wharton’s Jelly-Derived Mesenchymal Stem Cells: Phenotypic Characterization and Optimizing Their Therapeutic Potential for Clinical Applications

BONE REGENERATION

Bone Regeneration Using Wharton’s Jelly Mesenchymal Stem Cells

CANCER

Human Wharton’s jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin

Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling

CYSTIC FIBROSIS

The Potential of Wharton’s Jelly Derived Mesenchymal Stem Cells in Treating Patients with Cystic Fibrosis

DIABETES

Wharton’s Jelly Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes

MULTIPLE SCLEROSIS

Therapeutic Effect of Transplanted Human Wharton’s Jelly Stem Cell-Derived Oligodendrocyte Progenitor Cells (hWJ-MSC-derived OPCs) in an Animal Model of Multiple Sclerosis

NEURONAL REPAIR & NEW NERVE CELL FORMATION

The Secretome of Bone Marrow and Wharton Jelly Derived Mesenchymal Stem Cells Induces Differentiation and Neurite Outgrowth in SH-SY5Y Cells

Matrix Cells from Wharton’s Jelly Form Neurons and Glia

Neurotrophic factors from human Wharton’s jelly mesenchymal stem cells induce gliogenesis

Wharton’s jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research

Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton’s Jelly to Dopaminergic Neurons In Vitro: Potential Therapeutic Application for Parkinsonism

TISSUE REGENERATION

Wharton’s jelly mesenchymal stem cells promote wound healing and tissue regeneration

TRAUMATIC BRAIN INJURY

Wharton’s Jelly Transplantation Improves Neurologic Function in a Rat Model of Traumatic Brain Injury

 

Why people are flocking to Nova Cells

NCIM SCREENSHOT MARCH 2015Among the many things that draw people to Nova Cells Institute Mexico:

► It’s treatments are effective: NCIM’s use of primed adult (nonembryonic) stem cells along with its proprietary Beacon Factor has brought about swift neurologic improvements in not only adults but also in more than 95% of the children treated to-date. Many children with poor circulation and movement in their lower limbs have experienced the “pinking up” of cold, often oxygen starved (cyanotic) bluish tissue within hours of their treatment often followed by being able to move previously immobile toes, feet and even legs. Many parents with cell phones or video cameras in-hand have excitedly videotaped their children doing things with their bodies they previously could not do within hours of their NCIM treatment. Many of these videos or links to them are posted on this website at: http://novacellsinstitute.com/spina-bifida-updates.html

►Affordability (aka value for money invested in care): Patients, parents and others never have to deal with middle men, brokers, professional marketers or the like when it comes to Nova Cells Institute Mexico. NCIM was founded, in fact, by a group of people who wanted to create a business entity that puts people above huge profit margins. The steadfast refusal of NCIM to retain brokers or other professional sales or marketing people coupled with its dogged pursuit of cost savings in its lab and among its contracted doctors clinics & hospitals has made it possible for NCIM to consistently offer its patients treatments that run well below market. For instance, while many private clinics and hospitals doing stem cell therapies in Asia and China charge $35K USD or more to treat spina bifida children, cerebral palsy, Traumatic Brain Injury (TBI), and such, NCIM typically charges $15-17K USD (Roughly 50% less). In addition, 99% of NCIM neurologic treatments are done in a single day while some being done in Asia and elsewhere can take weeks on end to complete.

►NCIM’s Personal Touch: Nova Cells Institute Mexico was founded and is staffed by caring people who have devoted their lives to relieving suffering and effecting healing. When people call or email Nova Cells they typically have their call or email answered by Grace Odgers, Ph.D. cand., who delights in fielding questions and “filling in the blanks”. When questions or issues are raised that require input from a doctor or scientist, Grace quickly obtains this and passes it along. As part of NCIM’s “personal touch” philosophy, Grace and her husband, biochemist and NCIM director of laboratory Services Dr. Abel Pena, typically help out with getting NCIM patients and their family or caregivers to and from Mexico, and support them through every step of the treatment process while there. If you look closely at the many patient tendered articles on this website and on Facebook and other websites, you will often hear about how Grace and Dr. Abel “have became like family to us”.

And, unlike so many stem cell treatment programs, patients are not treated and turned loose. They invariably get follow-up emails and/or phone calls from NCIM staff especially Grace.

►NCIM Goes the Extra Mile: Nova Cells Institute Mexico primed stem cells, Beacon Factor, donor granulocyte therapy (for cancer) and other treatments have proved to a healing Godsend to so many people in and of themselves. However, this is not all there is to it. NCIM affiliated doctors plus experts in scientifically-validated therapeutic diets, nutrition, herbal medicine and more carefully review patient medical records and test results to determine what (if any) can be recommended that is likely to optimize healing and/or other aspects of the patient’s recovery and restoration, e.g., physical, cognitive, mood, etc. These are then passed on to the patient by NCIM doctors.

And, last but not least……

Nova Cells Institute Mexico offers free case evaluations which people can take advantage of by going to http://www.novacellsinstitute.com/how-to-submit.html

Killing cancer, not the cancer sufferer (Targeting & defeating cancer while leaving healthy cells unaffected)

On Sunday December 7 (2014) CBS’s famed 60 Minutes devoted a thirteen minute segment titled “Disrupting Cancer” to physician and billionaire businessman Patrick Soon-Shiong, MD‘s advocacy and use of the rapid gene sequencing of tumor cells to help zero in specific drugs or other agents that will eradicate them. Later the same day, Forbes’s writer Matthew Herper published an article in which he stated something virtually everyone doing cancer work knows, namely that “Everyone is looking to use DNA sequencing to better pick cancer drugs. And in some ways, Soon-Shiong is an odd person to pick as a spokesperson for this, because he’s just getting started. ” (Here Is What ’60 Minutes’ Didn’t Tell You About The Billionaire Who Is Trying To Disrupt Cancer Care).

This is not to say that with Dr. Soon-Shiong’s deep pockets and army of computer experts and researchers he will not wind up making major inroads in this area of biomedicine. And with cancer striking so many, progress is welcome whether it comes out of a one person lab or a research enterprise that fills buildings or is stretched across many continents.

Confident BusinessmanNova Cells is no stranger to finding ways to “disrupt cancer”. It has, in fact, focused on a treatment approach that combines attacking tumors using donor immune cells (from healthy young people) and specific compounds that gum up the inner machinery in cancer cells while leaving healthy cells. It has been a spectacularly successful quest that started with the treatment of a 71 year old gentleman from the Pacific Northwest who was in the last throes of end-stage prostate cancer that had spread into his liver and bones. He was, in fact, so bad off that NCIM doctors thought he might not live more than a handful of days, at best. But, like so many people struggling with cancer, he was a spirited fighter who simply would not entertain abandoning hope until, as he put it, “I take my last breathe”.

This determined chap knew the score going into treatment, namely that he was volunteering to undergo something very experimental in nature. But he was resolutely committed to “fighting the good fight”, even if this pitched battle proved his last. Seeing his determined spirit, the MDs set about stabilizing him to help insure he could handle the biological blitzkrieg (lightening war) that NCIM’s experimental tumor-killing method was expected to unleash in his body.

Three days later the doctors began daily treatments using cancer-fighting cells (called granulocytes) that had been previously isolated from the blood of many young, healthy volunteers and then combined and infused by intravenous (IV) means. In addition, he was to be given intentionally HLA mismatched umbilical cord stem cells.

If the treatment worked as anticipated, the donor granulocytes would attack the tumors and also send a “wake up call” to the immune system, i.e., alert the fellow’s own immune cells that something alien was present which they would then attack (One problem in cancer is that tumors send out biochemical signals that suppress the sufferer’s own innate tumor-fighting cells). In addition, the HLA mismatched umbilical cord blood stem cells would be attracted by growth factors secreted by the tumors, attach to them, and then be attacked by the patient’s own immune cells which would react to them as a foreign presence.

The outcome? He did had a mild immune reaction (rash) that was easily suppressed using an IV antihistamine. This is how NCIM’s own patient care coordinator, Grace Pena, Ph.D. cand., summed up what transpired:

“Within three days his face was pinkish and his hands were getting pink. He was eating so well that the staff could not believe it. After the 7th primed donor granulocyte treatment he was walking 1/2 mile around the hospital, and feeling great. He was feeling so good in fact that he decided to return to his home state of Washington to finish up a million dollar real estate deal. NCIM doctors and staff protested wanting him to finish the entire course of therapy but he was adamant about getting home, but promised to return and complete his care once his real estate deal was completed. This he did. By October his US oncologist reported that his PSA is 1.1, his prostate is smaller than a normal 20 year olds, and he could find no cancer at all. Also, his Alkaline Phosphatase level which was about 2,000 during his treatment had dropped to something around 89.”

This fellow remains in full remission to this day.

Following this exciting clinical success, other end-stage cancer patients were treated (prostate, breast, lung, others) using the same method. Fifty percent (50%) experienced tumor shrinkage (partial remission) while the rest (50%) went into full remission.

In addition, other cancer-fighting measures were tested both alone and in combination with the donor granulocytes & cord blood stem cells (Gr-UCSC). Those that resulted in tumor shrinkage or obliteration when used alone, as well as those that bolstered the anti-cancer impact of the Gr-UCSCs were retained.

Among these were two chemical compounds that throw a monkey wrench into the tiny power-generating factories (mitochondria) in tumor cells but do not adversely affect normal cells. They are, in technical parlance Patrick Soon-Shiong, MD, selective for malignant cells.

NCIM also selectively utilizes a unique injectable protein that amplifies the cancer-fighting activity of a patient’s own macrophages.

Returning now to that 60 Minutes segment: Dr. Soon-Shiong beamed about tackling cancer at an immunological level. Nova Cells doctors and staff wish him well in this quest, but can’t help adding that in many ways we left the starting gate years ago and are “already there” (That is, have made demonstrable progress and enjoyed great success).

If you’d like to know more about NCIM’s cancer treatment method, just click these links:

Click to read more about NCIM’s Gr-UCSC method of treating cancer

Click to access cancer patient write-ups

You can also email or call NCIM:

??????????Email NCIM at NCInfodesk@gmail.com

CELL PHONE - Free MS Call NCIM at 1-562-916-3410 (9 am to 7 pm Pacific Time, Monday through Friday)